|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| OTC Healthcare in France to 2009 |
|
|
|
|
€ 420,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Novembre 2005 |
Taille du document : |
126 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Pharmaceutical Packaging Market
80 pages | Avril 2002 |
This report will enable you to:Analyse the size of the UK market for pharmaceutical packaging between 1997 and 2006, by type: - cartons - containers - labels and leaflets - blister & strip p |
1 479,00 €
|
| |
| |
Healthcare In Northern Ireland
52 pages | Mai 2000 |
The Northern Ireland Presentation Includes:- The Structure Of The Health Service In Northern Ireland- Total Expenditure On Health & Personal Social Services- Number Of Inpatient Beds, BY Area- Occ |
327,00 €
|
| |
| |
OTC Analgesics in Germany
15 pages | Juillet 2002 |
The German market for OTC analgesics growth not so rapidly and reached a value of Euro 772 million (US$ 729 million) in 2001, an increase of 1.6% on the previous year.
Over the review period, the m |
198,00 €
|
| |
| |
Chinese Markets for Pharmaceuticals
225 pages | Janvier 2002 |
China's demand for pharmaceuticals has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic |
3 500,00 €
|
| |
| |
Chinese Markets for Pharmaceuticals
225 pages | Janvier 2002 |
China's demand for pharmaceuticals has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic |
2 835,00 €
|
| |
| |
Healthcare In Wales
50 pages | Mai 2000 |
The Welsh Presentation Includes:- The Structure Of The NHS In Wales- Revenue Expenditure On Health Services In Wales- Number Of Hospital Units - Number Of Available Inpatient Beds- Number Of Occupied |
327,00 €
|
| |
| |
Lifestyle Drugs Outlook to 2005
130 pages | Février 1999 |
Definition of lifestyle drugs : The disease, product and social characteristics that make a drug lifestyle drug.
Epidemiology : The patient potential for lifestyle drugs such as sexual dysfuncti |
795,00 €
|
| |
| |
Patient Power in the Pharmaceutical Industry: The shift towards more informed, more powerful consumers of drugs
119 pages | Juin 1999 |
The dramatic rise in patient power in recent years presents a new and challenging opportunity to pharmaceutical companies, healthcare providers and governments alike.
A great need exists for ph |
795,00 €
|
| |
| |
Pharmaceutical Mergers & Aquisitions: the third wave
160 pages | Février 1999 |
Historical assessment : The report identifies the factors that have driven the two historical waves of M&A activity, and analyses the relative importance of these factors through case studies.
795,00 €
|
|
| |
| |
The Generics Outlook 2001
242 pages | Février 2001 |
“By the year 2004, it is expected that the value of the total western European generics sector may have risen to $19 billion, representing almost 15% of allpharmaceuticals.
In the USA, the val |
955,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| OTC Healthcare in France to 2009 |
|
|
Introduction
This databook is a detailed information resource covering all the key data points
on OTC Healthcare in France. It includes comprehensive value, segmentation and
market share data. The databook supplies actual data to 2004 and full forecasts
to 2009.
Scope of this report
Contains information on seven categories including: Analgesics, Cough &
Cold preparations, Indigestion preparations and Other OTC healthcare products.
Provides market value and expenditure data by market, segment and subsegment.
Includes company data by category, as well as distribution channel data.
Contains market value segmentation by demographic and socioeconomic group.
Research and analysis highlights
The market for OTC healthcare in France increased between 1999-2004, growing
at an average annual rate of 2.4%.
The leading company
in the market in 2004 was Bayer AG. The second-largest player was Boiron, with
Bristol-Myers Squibb Company in third place.
Key reasons to
read this report
Discover the major quantitative trends affecting the OTC healthcare market.
Understand consumers' consumption and expenditure patterns.
Understand the future direction of the market with reliable historical data
and full five year forecasting.
|
|
|
PPLSEN
|
|
|
|
|
